Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cobra Pharmaceuticals has signed an agreement to re-launch Nutra Pharma's Cobroxin, an all-natural, non-addictive pain relieving homeopathic drug formulated using proteins from cobra venom.
Subscribe to our email newsletter
The first OTC pain reliever proven to treat Stage 2 (moderate to severe) chronic pain, Cobroxin will be marketed and distributed by Cobra.
Available as an oral spray, the analgesic is used to treat lower back pain, migraines, neck aches, shoulder pain, cramps and neuralgia, in addition to a topical gel for treating repetitive stress, arthritis and joint pain.
Nutra Pharma CEO Rik Deitsch said the marketing and promotional initiatives of the product are expected to begin in the third quarter of 2013.
"The anticipated rollout model will include direct response (radio, television and print) followed by a traditional commercial campaign to support retail sales in the general marketplace," Deitsch added.
"Cobra Pharmaceuticals will also begin international registrations later this year to bring Cobroxin into the identified lucrative foreign markets of Central America, South America, India and the European Union."